Assembly Biosciences, Inc. ASMB
22.15 USD -0.36 (-1.58%)
As ofNov 20, 2026, 2:33 PM EST
21.87 Day range 22.79
19.20 52-week range 39.65
- YTD
- -34.89%
- 1 year
- -39.71%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 72.30M | 28.52M | 7.16M | 0 | 6.25M | |
| 72.30M | 28.52M | 7.16M | 0 | 6.25M | |
| -12.12M | -45.42M | -64.65M | -94.11M | -132.69M | |
| -6.12M | -40.18M | -61.23M | -93.09M | -129.85M | |
| -0.55 | -6.69 | -13.38 | -23.08 | -36.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 58.45M | 38.34M | 19.84M | 52.42M | 45.63M | |
| 257.59M | 119.17M | 136.82M | 101.79M | 191.06M | |
| 50.84M | 85.81M | 95.73M | 19.13M | 22.13M | |
| 2.63M | 3.09M | 2.34M | 3.46M | 6.48M | |
| 206.75M | 33.36M | 41.10M | 82.66M | 168.93M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -41.09M | -51.12M | 22.74M | -84.46M | -93.40M | |
| -113.47M | 40.17M | -69.14M | 90.64M | 26.52M | |
| 174.67M | 29.45M | 13.82M | 614.00K | 53.06M | |
| -66.00K | -28.00K | -231.00K | -102.00K | -2.24M | |
| 20.11M | 18.50M | -32.58M | 6.79M | -13.82M |
